Page 294 - Read Online

12 h for 3 days and finally 50 mg hydrocortisone every shock and unresponsive to fluids and vasopressor
[9]
24 h for 3 days) or placebo groups. The results indicated administration.
no significant difference in mortality between treatment Review of the literature indicates the need to conduct
and the placebo group. But shock reversal was achieved carefully planned clinical trials to resolve controversies
more quickly in treatment group compared to the placebo and to provide a more reliable result. [13]
group, regardless of the adrenal function (P = 0.001).
However, the proportion of patients, in whom shock Financial support and sponsorship
reversal was achieved, was similar between the 2 groups. Nil.
There was also evidence of increased risk of superinfection
in treatment group (combined odds ratio: 1.37; 95% Conflicts of interest
confidence interval: 1.05‑1.79). The strength of the study There are no conflicts of interest.
was its large sample size, randomization and power of
study was 80%. The limitation of this study is that the REFERENCES
treatment group received steroids as late as 72 h. Earlier
studies have shown that steroids have been beneficial only 1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM,
if given early (< 8 h). [9] Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use
of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference
All meta‑analysis confirmed improved shock reversal with Committee. American College of Chest Physicians/Society of Critical Care
[3]
LDC use. Subsequent analysis found that severely ill 2. Medicine. Chest 1992;101:1644‑55.
Yarema TC, Yost S. Low‑dose corticosteroids to treat septic shock: a critical
patients were more likely to benefit from corticosteroid literature review. Crit Care Nurse 2011;31:16‑26.
therapy. One analysis suggested that it may be harmful in 3. Gesensway D. Why steroids are making a comeback for treating septic shock.
less ill patients. [3] Todays Hospitalist 2006;5. Available from: http://www.todayshospitalist.com/
index.php?b=articles_read and cnt=176. [Last accessed on 2014 Jun 02].
While on steroids, according to a previous study done, 4. David KA, Mancebo J. Corticosteroid Therapy in septic shock. UpToDate
[10]
there was a certain increase in side effects of secondary 2014;1. Available from: http://www.uptodate.com/contents/corticosteroid‑
infections, gastrointestinal bleeding and increased blood 5. therapy‑in‑septic‑shock. [Last accessed on 2015 Jan 11].
Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol
glucose. However, these problems could be due to in critically ill patients. N Engl J Med 2004;350:1629‑38.
terminal illness. This probably indicates the need for a 6. Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM,
larger clinical trial. [2] Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet‑Riffaud P, Bellissant E.
Effect of treatment with low doses of hydrocortisone and fludrocortisone
Current recommendations [3,11,12] suggest: on mortality in patients with septic shock. JAMA 2002;288:862‑71.
• Administering intravenous corticosteroid therapy 7. Keh D, Boehnke T, Weber‑Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD,
(200‑300 mg/day) to adult patients with severe septic Doecke WD, Falke KJ, Gerlach H. Immunologic and hemodynamic effects
shock (defined as a systolic blood pressure less than of “low‑dose” hydrocortisone in septic shock: a double‑blind, randomized,
placebo‑controlled, crossover study. Am J Respir Crit Care Med 2003;167:512‑20.
90 mmHg for more than 1 h despite both adequate fluid 8. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG,
resuscitation and vasopressor administration); Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH,
• Not administering the corticosteroid to patients without Payen D, Briegel J; CORTICUS Study Group. Hydrocortisone therapy for
shock or patients with less severe shock (defined as those 9. patients with septic shock. N Engl J Med 2008;358:111‑24.
Toma A, Stone A, Green RS, Gray S. Steroids for patients in septic shock:
in whom fluid resuscitation and vasopressor therapy have the results of the CORTICUS trial. CJEM 2011;13:273‑6.
restored hemodynamic instability); 10. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, Fisher CJ Jr.
• ACTH test prior to administering steroids in sepsis is not Corticosteroid treatment for sepsis: a critical appraisal and meta‑analysis of
recommended; the literature. Crit Care Med 1995;23:1430‑9.
• Typically administer hydrocortisone for 57 days and taper 11. Gandhi NR, Asudani DG. What is the role of steroids in septic shock?
Hospitalist 2012;5. Available from: http://www.the‑hospitalist.org/article/
the dose as guided by the clinical response. what‑is‑the‑role‑of‑steroids‑in‑septic‑shock/. [Last accessed on 2015 Jan 11].
12. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE,
The impairment of hypothalamic‑pituitary‑adrenal axis in Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR,
sepsis has not been resolved yet. Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR,
Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis
The most uniform finding by almost all trials is that Campaign Guidelines Committee including the Pediatric Subgroup. Surviving
corticosteroid may accelerate shock reversal. At this sepsis campaign: international guidelines for management of severe sepsis
and septic shock: 2012. Crit Care Med 2013;41:580‑637.
time, the most supported view is LDC should be 13. Vincent JL. Steroids in sepsis: another swing of the pendulum in our clinical
administered to those patients who are in septic trials. Crit Care 2008;12:141.

Plast Aesthet Res || Vol 2 || Issue 5 || Sep 15, 2015 285